- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05386641
Risk Factors for Shoulder Joint Motion Restriction
May 25, 2022 updated by: Nilufer Kablan, Istanbul Medeniyet University
Risk Factors for Shoulder Joint Motion Restriction in Breast Cancer Survivors
In breast cancer patients, limitation of shoulder joint movement may occur following cancer treatment.
Shoulder limitation causes a significant decrease in the patient's participation in activities of daily living.
The aim of the study is to define these limitations, to evaluate in detail all the structures that cause the problem, and to determine the causes of the limitations in patients with shoulder joint movement limitation developed after breast cancer survivors.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
- Other: measurement of tissue stiffness (N/m)
- Other: measurement of passive muscle tone (Hz)
- Other: measurement of creep of tissue
- Other: measurement of the range of shoulder joint motion
- Other: measurement of skin temperature
- Other: measurement of pain
- Other: measurement of pain pressure threshold
- Other: measurement of grip strength
Study Type
Observational
Enrollment (Anticipated)
72
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nilüfer Kablan, PhD
- Phone Number: +905067638556
- Email: niluferkablan@yahoo.com
Study Contact Backup
- Name: Gülser Cinbaz, MSc
- Phone Number: +905558503576
- Email: gulser.cinbaz@gmail.com
Study Locations
-
-
-
Istanbul, Turkey
- İstanbul Medeniyet University
-
Contact:
- Gülser Cinbaz
- Phone Number: +905558502576
- Email: gulser.cinbaz@gmail.com
-
Principal Investigator:
- Nilüfer Kablan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
Breast cancer survivors with or without shoulder joint restriction will be evaluated
Description
Inclusion Criteria:
- Women between the ages of 30-60
- Having breast cancer treatment within 5 years
Exclusion Criteria:
- Not having agreed to participate in the study
- Presence of additional orthopedic (scoliosis, etc.), neurological (multiple sclerosis, stroke, etc.) and rheumatological diseases (ankylosing spondylitis, rheumatoid arthritis, etc.) that will affect upper extremity functions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Experimental Group
Breast cancer survivors with shoulder joint motion restriction
|
Stiffness values will be measured with myotonPro on centers of coordination located along the myofascial chain
muscle tones will be measured with myotonPro on centers of coordination located along along the myofascial chain
creep of tissue will be measured with myotonPro on centers of coordination located along the myofascial chain
The range of shoulder flexion, abduction, extension and external-internal rotation movements will be measured with a universal goniometer.
measurements will be taken by the thermographic camera
Pain will be evaluated by visual analog scale (VAS)
Pain pressure threshold will be evaluated by a digital algometer
The grip strength of both hand will be evaluated by "hand-held" dynamometer.
|
|
Control group
Breast cancer survivors without shoulder joint motion restriction
|
Stiffness values will be measured with myotonPro on centers of coordination located along the myofascial chain
muscle tones will be measured with myotonPro on centers of coordination located along along the myofascial chain
creep of tissue will be measured with myotonPro on centers of coordination located along the myofascial chain
The range of shoulder flexion, abduction, extension and external-internal rotation movements will be measured with a universal goniometer.
measurements will be taken by the thermographic camera
Pain will be evaluated by visual analog scale (VAS)
Pain pressure threshold will be evaluated by a digital algometer
The grip strength of both hand will be evaluated by "hand-held" dynamometer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
measurement of tissue stiffness (N/m)
Time Frame: Baseline
|
Stiffness values will be measured with myotonPro on centers of coordination located along the myofascial chain
|
Baseline
|
|
measurement of passive muscle tone (Hz)
Time Frame: Baseline
|
muscle tones will be measured with myotonPro on centers of coordination located along the myofascial chain
|
Baseline
|
|
measurement of creep of tissue
Time Frame: Baseline
|
creep of tissue will be measured with myotonPro on centers of coordination located along the myofascial chain
|
Baseline
|
|
measurement of the range of shoulder joint motion
Time Frame: Baseline
|
The range of shoulder flexion, abduction, extension and external-internal rotation movements will be measured with a universal goniometer.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
measurement of skin temperature
Time Frame: Baseline
|
measurements will be taken from the area covering 3 cm of the surgical incision with a P45 thermographic camera with high thermal sensitivity
|
Baseline
|
|
measurement of pain
Time Frame: Baseline
|
Pain will be evaluated by visual analog scale (VAS).
In the scale, the patient is asked to mark the most appropriate pain intensity on a scale ranging from 0 (no pain) to 10 (tolerable pain).
The higher the score, the greater the pain intensity.
|
Baseline
|
|
measurement of pain pressure threshold
Time Frame: Baseline
|
Pain pressure threshold will be evaluated by a digital algometer
|
Baseline
|
|
measurement of grip strength
Time Frame: Baseline
|
The grip strength of both hand will be evaluated by "hand-held" dynamometer.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 15, 2022
Primary Completion (Anticipated)
August 15, 2023
Study Completion (Anticipated)
February 15, 2024
Study Registration Dates
First Submitted
May 18, 2022
First Submitted That Met QC Criteria
May 18, 2022
First Posted (Actual)
May 23, 2022
Study Record Updates
Last Update Posted (Actual)
May 31, 2022
Last Update Submitted That Met QC Criteria
May 25, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022/0226
Plan for Individual participant data (IPD)
Study Data/Documents
-
Individual Participant Data Set
Information identifier: 18192154
-
Individual Participant Data Set
Information identifier: 25977305
-
Individual Participant Data Set
Information identifier: 26079868
-
Individual Participant Data Set
Information identifier: 29332760
-
Individual Participant Data Set
Information identifier: 32031629
-
Individual Participant Data Set
Information identifier: 32767329
- Individual Participant Data Set
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.